Rainier Acquisition Corporation closed its initial public offering of 7,500,000 units at $10.00 each, generating $75,000,000 in gross proceeds before underwriting discounts and offering expenses. Each unit includes one Class A ordinary share and one-quarter of one redeemable warrant, with each whole warrant exercisable for one Class A ordinary share at $11.50. The units began trading on the Nasdaq Capital Market on Aug. 27, 2026, under RNAQU; the shares and warrants are expected to trade separately under RNAQ and RNAQW. Rainier is seeking a business combination, with a stated focus on global life sciences, while retaining flexibility across industries and regions. The existing record also covers Inflection Point Acquisition Corp. VIII, a separate SPAC that priced 25,000,000 units at $10.00 each and planned to begin trading under IPHXU on Aug. 28.